Sveriges mest populära poddar

TechCrunch Startup News

Nyheter Teknologi

Israeli biotech startup mana.bio launches AI-fueled programmable drug therapy

4 min•13 oktober 2023

Israeli biotech startup Mana.bio has been planning to launch its programmable drug treatment solution for months, and decided to forge ahead in spite of the attacks that happened this past weekend in the country.

Learn more about your ad choices. Visit podcastchoices.com/adchoices

Fler avsnitt av TechCrunch Startup News

AI data startup Micro1 reaches $500M gross run rate amid AI training boom; plus, Japanese space tech startup Letara expands beyond satellite thrusters

24 aug.•8 min

Apollo Atomics wants to make nuclear power cheaper by shrinking an overlooked part; plus, Detroit startup Grounded raises $5M to customize electric and gas-powered vans

21 aug.•7 min

AI isn’t close to curing cancer. Vivodyne says it knows what it will take; plus, TerraPower’s nuclear reactor has a secret weapon for powering AI data centers

20 aug.•11 min

DOJ’s probe into Andreessen Horowitz over board seats baffles VCs; plus, Etched’s valuation doubles to $21B in a month

19 aug.•7 min

Sound-powered fire protection startup gets $15M to snuff out fires before they turn catastrophic; plus, Wispr looks beyond dictation

18 aug.•7 min

SpaceX officially closes its Cursor acquisition; plus, Stripe will reportedly acquire AI gateway startup OpenRouter for $7B+

17 aug.•3 min

How a $250 million acquisition collapsed into allegations of fraud and forged signatures

14 aug.•7 min

Reservoir raises $8M to make water heaters that people and the grid will actually want; plus, AI code-testing startup Blacksmith’s valuation jumps almost 10x

13 aug.•9 min

Tech industry is buzzing after a Claude agent hacked into a gym; plus, Kyoto Fusioneering starts work on key fusion power plant device

12 aug.•10 min

Discovered Materials is playing AI whack-a-mole to hunt cooler chips

11 aug.•6 min

TechCrunch Startup News med TechCrunch finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.